image

The best stocks to buy since 1993

Latest issue now available

EMIS - Well set for a big beat on forecasts

October 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • EMIS
  • Price:
  • 1045p
The story has never been better and EMIS is firing on all cylinders as NHS health records move towards a target of being fully digital by 2020. This is reflected in the strong set of interims with sales ahead by 17% to £77.8m (8% organic) and operating profit up 16% to £16.9m. Adjusted eps was up 18% to 20.5p.  EMIS’ historical mainstay is in GP systems (the legacy EMIS software and the internet based EMISWeb), which hold 40m patient records and here the total number of practices was broadly held at 5,121, giving EMIS a 54% share of GP systems.The number of EMISWeb converts went up by around 200 to 4,431 so most of the base is converted to the internet version but EMISWeb has been spreading its tentacles to Community Care ven ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe